Terms: = Skin cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
113 results:
1. Phytocompounds from essential oil of Mentha aquatica L. cv. Lime prevent vemurafenib-promoted skin carcinogenesis via inhibiting hras
Chang CT; Chen YH; Shyur LF
Phytomedicine; 2024 Jan; 122():155161. PubMed ID: 37939409
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
Wen S; Zeng J; Zhong L; Ye J; Lai X
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract] [Full Text] [Related]
4. Sebaceous nevus of Jadassohn: review and clinical-surgical approach.
Neto MPDS; Assis BR; Andrade GR
An Bras Dermatol; 2022; 97(5):628-636. PubMed ID: 35863943
[TBL] [Abstract] [Full Text] [Related]
5. Actionable Mutation Profile of Sun-Protected Melanomas in South America.
Hsieh R; Nico MMS; Camillo CMC; Oliveira KK; Carraro DM; Sangueza M; Lourenço SV
Am J Dermatopathol; 2022 Oct; 44(10):741-747. PubMed ID: 35503891
[TBL] [Abstract] [Full Text] [Related]
6. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of Crizotinib treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
Robertson SJ; Orme L; Teixeira R; Shamassi M; Newell F; Patch AM; Yeh I; Gard G; Wilmott J; Jackett L; LeBoit P; Fellowes A; MacArthur G; Fox S; Hayward NK; Bastian B; Scolyer R; Waddell N; Penington A; Shackleton M
JAMA Dermatol; 2021 Jul; 157(7):836-841. PubMed ID: 34076666
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Landscapes of Acral Melanomas in East Asia.
Chang JW; Hsieh JJ; Wu CE; Lim AH; Ng CC; Teh BT; Chan JY
Cancer Genomics Proteomics; 2021; 18(1):83-92. PubMed ID: 33419898
[TBL] [Abstract] [Full Text] [Related]
9. Human papillomavirus-negative epithelial proliferations resembling condylomata acuminata in a patient receiving vemurafenib for Stage IV melanoma.
Peters MA; Geukes Foppen MH; Blank CU; Crijns MB
J Cancer Res Ther; 2020; 16(1):170-172. PubMed ID: 32362631
[TBL] [Abstract] [Full Text] [Related]
10. Cold Atmospheric Plasma and Silymarin Nanoemulsion Activate Autophagy in Human Melanoma Cells.
Adhikari M; Adhikari B; Ghimire B; Baboota S; Choi EH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178401
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A
Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996
[TBL] [Abstract] [Full Text] [Related]
12. Personalized and targeted mutational analysis of multiple second primary melanomas under kinase inhibitors.
Donati M; Zelano G; Coppola R; Cinelli E; Verri M; Persichetti P; Perrella E; Devirgiliis V; Calvieri S; Crescenzi A; Panasiti V
Ital J Dermatol Venerol; 2021 Oct; 156(5):593-598. PubMed ID: 31804055
[TBL] [Abstract] [Full Text] [Related]
13. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
Precazzini F; Pancher M; Gatto P; Tushe A; Adami V; Anelli V; Mione MC
Dev Biol; 2020 Jan; 457(2):215-225. PubMed ID: 30998907
[TBL] [Abstract] [Full Text] [Related]
14. Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC.
Hebart H; Kiehl M; Tomasek J; Csoszi T; Koukakis R; Kafatos G; Kuhn A; Bjorklof K; Demonty G; Buchler T
Adv Ther; 2019 Mar; 36(3):670-683. PubMed ID: 30689133
[TBL] [Abstract] [Full Text] [Related]
15. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
[TBL] [Abstract] [Full Text] [Related]
17. Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.
Gambichler T; Rüddel I; Hessam S; Bechara FG; Stockfleth E; Schmitz L
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1485-1491. PubMed ID: 29478287
[TBL] [Abstract] [Full Text] [Related]
18. The levels of mutant k-ras and mutant n-ras are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.
Booth L; Roberts JL; Poklepovic A; Kirkwood J; Sander C; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Cancer Biol Ther; 2018 Feb; 19(2):132-137. PubMed ID: 29219657
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of (fli:GFP) Casper Zebrafish Embryos as a Model for Human Conjunctival Melanoma.
Pontes KCS; Groenewoud A; Cao J; Ataide LMS; Snaar-Jagalska E; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6065-6071. PubMed ID: 29204645
[TBL] [Abstract] [Full Text] [Related]
20. Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.
Picard A; Pedeutour F; Peyrade F; Saudes L; Duranton-Tanneur V; Chamorey E; Cardot-Leccia N; Sudaka A; Ettaiche M; Benchetrit M; Poissonnet G; Weinbreck N; Dadone B; Lacour JP; Passeron T; Montaudié H
JAMA Dermatol; 2017 Apr; 153(4):291-298. PubMed ID: 28259104
[TBL] [Abstract] [Full Text] [Related]
[Next]
